Literature DB >> 1657812

Renal tissue mast cells in liver diseases.

A Yoshimura1, W Mori.   

Abstract

Renal tissue mast cell counts were studied in autopsied cases of liver diseases. In cirrhosis and fibrosis of the liver, cases with hepato-renal syndrome showed a significant decrease in renal tissue mast cell counts as compared to those without hepato-renal syndrome. On the other hand, a significant increase in the number of mast cells was noted in cases with hepato-renal syndrome as compared to those without hepato-renal syndrome in fulminant hepatitis. These results suggest that renal tissue mast cells may play an important role in the onset of acute renal failure in liver diseases.

Entities:  

Mesh：

Year:  1991        PMID： 1657812     DOI： 10.1007/bf02583997

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  8 in total

1.  Altered renal and platelet arachidonic acid metabolism in cirrhosis.

Authors:  G Laffi; G La Villa; M Pinzani; G Ciabattoni; P Patrignani; M Mannelli; F Cominelli; P Gentilini
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

2.  Recovery from "hepatorenal syndrome" after orthotopic liver transplantation.

Authors:  S Iwatsuki; M M Popovtzer; J L Corman; M Ishikawa; C W Putnam; F H Katz; T E Starzl
Journal:  N Engl J Med       Date:  1973-11-29       Impact factor: 91.245

3.  Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.

Authors:  S P Wilkinson; V Arroyo; B G Gazzard; H Moodie; R Williams
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

4.  Renal and intrarenal blood-flow in cirrhosis of the liver.

Authors:  M C Kew; P W Brunt; R R Varma; K J Hourigan; H S Williams; S Sherlock
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

5.  [Renal mastocytosis and secondary aldosteronism].

Authors:  I Dévényi; L Szücs; D Tessmann; H Schill
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1968

6.  Renal failure in the patient with cirrhosis. The role of active vasoconstriction.

Authors:  M Epstein; D P Berk; N K Hollenberg; D F Adams; T C Chalmers; H L Abrams; J P Merrill
Journal:  Am J Med       Date:  1970-08       Impact factor: 4.965

7.  Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.

Authors:  R D Zipser; G H Radvan; I J Kronborg; R Duke; T E Little
Journal:  Gastroenterology       Date:  1983-04       Impact factor: 22.682

8.  High susceptibility to ADP-induced thrombus formation in mast cell-deficient W/Wv mice.

Authors:  K Hatanaka; M Minamiyama; K Tanaka; T Taguchi; S Tajima; Y Kitamura; A Yamamoto
Journal:  Thromb Res       Date:  1985-11-15       Impact factor: 3.944
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.